On November 4, 2021, Global Liver Institute was joined by members of the liver advocacy community to provide their input on NASH, including their perspectives on their condition, its impact on daily life, and the urgency around developing therapies. The NASH EL-PFDD Meeting is a critical first step in providing the medical community with a deeper understanding of NASH directly from the patients and caregivers that have been impacted most.
